Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Operating Expenses (2018 - 2025)

TransMedics has reported Operating Expenses over the past 8 years, most recently at $72.1 million for Q4 2025.

  • Quarterly results put Operating Expenses at $72.1 million for Q4 2025, up 13.84% from a year ago — trailing twelve months through Dec 2025 was $254.2 million (up 13.2% YoY), and the annual figure for FY2025 was $254.2 million, up 13.2%.
  • Operating Expenses for Q4 2025 was $72.1 million at TransMedics, up from $61.3 million in the prior quarter.
  • Over the last five years, Operating Expenses for TMDX hit a ceiling of $72.1 million in Q4 2025 and a floor of $11.3 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $41.5 million (2023), compared with a mean of $40.9 million.
  • Biggest five-year swings in Operating Expenses: soared 191.63% in 2023 and later fell 17.5% in 2024.
  • TransMedics' Operating Expenses stood at $18.3 million in 2021, then soared by 50.06% to $27.5 million in 2022, then skyrocketed by 64.91% to $45.3 million in 2023, then surged by 39.82% to $63.4 million in 2024, then increased by 13.84% to $72.1 million in 2025.
  • The last three reported values for Operating Expenses were $72.1 million (Q4 2025), $61.3 million (Q3 2025), and $60.0 million (Q2 2025) per Business Quant data.